Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells

Fig. 5

Expression levels of the epigenetically active enzymes of Table 2. mRNA baseline expression levels of the seven H3K4 demethylases and five methyltransferases already depicted in Table 2. Expression levels of the three cell lines were determined by Affymetrix HG-U133A epression arrays by Coldren et al. 2006 and signal intensities as reposited at the GEO database (GSE4342) were plotted. [34]

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us